These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8112240)

  • 1. Systemic lupus erythematosus associated with use of valproate.
    Asconapé JJ; Manning KR; Lancman ME
    Epilepsia; 1994; 35(1):162-3. PubMed ID: 8112240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced systemic lupus erythematosus in a patient with partial trisomy of chromosome 9 and epilepsy.
    Gigli GL; Scalise A; Pauri F; Silvestri G; Diomedi M; Placidi F; Grazia Pomponi M; Masala C
    Epilepsia; 1996 Jun; 37(6):587-8. PubMed ID: 8641238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible induction of systemic lupus erythematosus by valproate.
    Bleck TP; Smith MC
    Epilepsia; 1990; 31(3):343-5. PubMed ID: 2111770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus anticoagulant induced by the combination of valproate and lamotrigine.
    Echaniz-Laguna A; Thiriaux A; Ruolt-Olivesi I; Marescaux C; Hirsch E
    Epilepsia; 1999 Nov; 40(11):1661-3. PubMed ID: 10565597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic manifestations of long-term valproate therapy.
    May RB; Sunder TR
    Epilepsia; 1993; 34(6):1098-101. PubMed ID: 8243362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematological disturbances during long-term valproate therapy.
    Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
    Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate and platelet counts.
    Eastham RD; Jancar J
    Br Med J; 1980 Jan; 280(6208):186. PubMed ID: 6766772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
    Loiseau P
    Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced systemic lupus erythematous: A case report.
    Boussaadani Soubai R; Lahlou M; Tahiri L; Rabhi S; Harzy T; Bono W
    Rev Neurol (Paris); 2013 Mar; 169(3):278-9. PubMed ID: 23522291
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
    De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
    J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal hyperammonemia in a patient with systemic lupus erythematosus.
    Ichikawa H; Amano T; Kawabata K; Kushiro M; Wada J; Nagake Y; Makino H
    Intern Med; 1998 Aug; 37(8):700-3. PubMed ID: 9745859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate and thrombocytopenia.
    Miyake S; Honda K; Kimura S; Ike Y
    Brain Dev; 1979; 1(4):319-22. PubMed ID: 121951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.
    Conley EL; Coley KC; Pollock BG; Dapos SV; Maxwell R; Branch RA
    Pharmacotherapy; 2001 Nov; 21(11):1325-30. PubMed ID: 11714204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.